Tumor Microenvironment: Clinical Trials

13 trials for Tumor Microenvironment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 3 not yet recruiting, 2 completed, 2 unknown. 5 Not applicable, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable5Not yet recruiting 2, Recruiting 2, Completed 1
Phase 22Recruiting 1, Withdrawn 1

Follow Tumor Microenvironment: new trials by email Literature Review of Tumor Microenvironment trials Research Report on Tumor Microenvironment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Supervised Aerobic Exercise on Biomarkers in Patients With nSCLC Receiving Immunotherapy
Exercise - Non-Small Cell Lung Cancer, Aerobic Exercise
Not applicableNot yet recruitingIzmir Bakircay University782027-01-042026-10-21
A Pan-Cancer Retrospective Study on the Relationship Between Tumor Microenvironment Composition and Efficacy of Antibody-Based Antitumor Therapy
Tumor Microenvironment, Antibody
Active not recruitingTianjin Medical University Cancer Institute and Hospital3002026-03-012026-05-13
Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)
MRS study, blood samples - Glioblastoma, MRI Spectroscopy
Not applicableNot yet recruitingCentre Hospitalier Universitaire, Amiens302025-12-012025-11-19
Metformin as a Metabolic Intervention in Oesophageal Adenocarcinomas to Improve Response to Neoadjuvant Chemoradiotherapy
Metformin - Oesophageal Adenocarcinoma, Tumor Microenvironment
Phase 2RecruitingAmsterdam UMC, location VUmc142025-03-092025-07-10
Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study
Chemotherapy - Osteosarcoma, Transcriptome
Not yet recruitingPeking University People's Hospital1002025-03-012025-01-24
Organoid Models of Hepatocellular Carcinoma
organoids models - Hepatocellular Carcinoma, Organoids
Not applicableRecruitingFondazione Policlinico Universitario Agostino Gemelli IRCCS1502024-10-012026-09-21
Will a Pre-therapy Exercise Intervention Improve the Outcomes of Patients With Advanced Oesophageal Cancer?
Low intensity exercise, High intensity exercise - Oesophageal Adenocarcinoma, T Cells
Not applicableRecruitingUniversity of Surrey502024-04-262026-02-02
Effect of Low-dose Radiotherapy on Tumor Immune Microenvironment in Oligometastases of NSCLC After Immunotherapy
low dose radiotherapy - Low-dose Radiotherapy, Tumor Microenvironment
Phase 2WithdrawnHetian District People's Hospital2024-03-182024-04-25
Clinical Study of Lung Protective Ventilation Strategies and Tumor Microenvironment
Lung protective ventilation strategy - Tumor Microenvironment
Not applicableCompletedAffiliated Hospital of Nantong University602024-01-252026-03-25
Mechanism Study to Investigate Difference in Efficacy of Neoadjuvant Chemoimmunotherapy in Lung Squamous Cell Carcinoma
Pathological response assessment - Tumor Microenvironment, Lung Squamous Cell Carcinoma
UnknownTang-Du Hospital402024-01-242024-05-30
The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC
Nasopharyngeal Carcinoma, Pathologic Complete Response
RecruitingJiangxi Provincial Cancer Hospital3002024-01-012024-02-08
Impact of Immuno-Oncologic Agent on Neoadjuvant Chemotherapy in Triple Negative Breast Cancer
Visium, Whole Genome Sequencing(WGS)/Whole Transcriptome Sequencing(WTS) - Triple Negative Breast Cancer, Neoadjuvant Chemotherapy
UnknownSamsung Medical Center502023-03-022023-06-20
Tumor Microenvironment in Gastric Cancer Patients Treated With Combined Immunotherapy and Chemotherapy
SOX plus PD-1 inhibitor, Gastroscopic biopsy - Gastric Cancer, Tumor Microenvironment
CompletedChinese PLA General Hospital152022-07-012026-10-15

Narrower conditions

Adenocarcinoma Of Esophagus (2)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Esophageal Neoplasms (2)  ·  Motor Activity (2)  ·  Adenocarcinoma (1)  ·  Carcinoma, Hepatocellular (1)  ·  Colorectal Neoplasms (1)  ·  Digestive System Diseases (1)  ·  Glioblastoma (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Osteosarcoma (1)  ·  Pathologic Complete Response (1)  ·  Stomach Neoplasms (1)  ·  Triple Negative Breast Neoplasms (1)

Broader conditions

Neoplasms (11)  ·  Neoplasms by Site (9)  ·  Digestive System Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Digestive System Diseases (4)  ·  Gastrointestinal Diseases (4)  ·  Gastrointestinal Neoplasms (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Carcinoma (3)  ·  Head and Neck Neoplasms (3)  ·  Behavior (2)  ·  Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Esophageal Diseases (2)  ·  Lung Diseases (2)

Interventions

Blood Specimen Collection (1)  ·  Drug Therapy (1)  ·  Exercise (1)  ·  High-Intensity Interval Training (1)  ·  Immune Checkpoint Inhibitors (1)  ·  Metformin (1)  ·  Radiotherapy (1)

Sponsors

Affiliated Hospital of Nantong University (1)  ·  Amsterdam UMC, location VUmc (1)  ·  Centre Hospitalier Universitaire, Amiens (1)  ·  Chinese PLA General Hospital (1)  ·  Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)  ·  Hetian District People's Hospital (1)  ·  Izmir Bakircay University (1)  ·  Jiangxi Provincial Cancer Hospital (1)  ·  Peking University People's Hospital (1)  ·  Samsung Medical Center (1)  ·  Tang-Du Hospital (1)  ·  Tianjin Medical University Cancer Institute and Hospital (1)  ·  University of Surrey (1)

Countries

China (6)  ·  France (1)  ·  Italy (1)  ·  Netherlands (1)  ·  South Korea (1)  ·  United Kingdom (1)

Top investigators

Adam Frampton, PhD (1)  ·  Fatma D Arslan, MD, Prof. (1)  ·  Francesca Romana Ponziani, PI (1)  ·  Hanneke W.M. van Laarhoven, MD, PhD (1)  ·  Jingao Li, PhD (1)  ·  Melih Zeren, Assoc.Prof (1)  ·  Murat Akyol, MD, Prof. (1)  ·  Sarah Derks, MD PhD (1)  ·  Yongtao Gao, Master (1)

Results publications

PMID 34019806